Development of improved procedures for sample preparation and storage of biological specimens are critical for diagnosis of human diseases, particularly cancer, for which positive cells are rare. Recent improvements in sample preparation and storage of cervical specimens led to significant increase in sensitivity and accuracy of cervical cancer screening. Although important, there have been few improvements in sample preparation, handling and storage of other biological specimens (e.g. fine needle aspirates or other biopsy materials). Problems associated with specimen handling include cell loss and cell clumping. Sample loss resulting from conventional biological specimen processing conditions such as fixation and permeabilization, used for intracellular immunophenotyping, is a well documented phenomenon. If the sample is limited, or cells of interest are rare, cell loss is a significant problem hampering research, diagnosis, patient monitoring, and clinical studies. This SBIR aims to develop a simple procedure to reduce cell loss associated with sample processing and intracellular immunophenotyping, as well as cell clumping. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA120297-01
Application #
7081153
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Sorbara, Lynn R
Project Start
2006-08-01
Project End
2007-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
1
Fiscal Year
2006
Total Cost
$149,859
Indirect Cost
Name
One Cell Systems, Inc
Department
Type
DUNS #
858837388
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Bailey, Sean T; Smith, Aleisha M; Kardos, Jordan et al. (2017) MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma. Nat Commun 8:15770
Krishnan, Bhavani; Rose, Tracy L; Kardos, Jordan et al. (2016) Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma. JAMA Oncol :
Rose, Tracy L; Deal, Allison M; Krishnan, Bhavani et al. (2016) Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era. Cancer 122:2988-95
Bailey, Sean T; Zhou, Bing; Damrauer, Jeffrey S et al. (2014) mTOR inhibition induces compensatory, therapeutically targetable MEK activation in renal cell carcinoma. PLoS One 9:e104413